V.A. Nasonova Research Institute of Rheumatology


Forschungseinrichtung

Standort der Organisation:
Moskau, Russische Föderation


Publikationen in Kooperation mit FAU-Wissenschaftlerinnen und Wissenschaftlern


Elhai, M., Boubaya, M., Distler, O., Smith, V., Matucci-Cerinic, M., Alegre Sancho, J.J.,... Allanore, Y. (2019). Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: A prospective cohort study. Annals of the Rheumatic Diseases. https://dx.doi.org/10.1136/annrheumdis-2018-214816
Wu, W., Jordan, S., Graf, N., Pena, J.D.O., Curram, J., Allanore, Y.,... Puttini, P.S. (2019). Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Annals of the Rheumatic Diseases, 78(5), 648-656. https://dx.doi.org/10.1136/annrheumdis-2018-213455
Jaeger, V.K., Siegert, E., Hachulla, E., Airo, P., Valentini, G., Matucci-Cerinic, M.,... Walker, U.A. (2018). Racial differences in SSc disease presentation: a European scleroderma trials and research group (EUSTAR) study. (pp. 9S-9S).
Elhai, M., Distler, O., Smith, V., Matucci-Cerinic, M., Alegre-Sancho, J.J., Truchetet, M.-E.,... Allanore, Y. (2018). RITUXIMAB IN SYSTEMIC SCLEROSIS : SAFETY AND EFFICACY DATA FROM THE EUSTAR NETWORK. (pp. 122-122).
Elhai, M., Meune, C., Boubaya, M., Avouac, J., Hachulla, E., Balbir-Gurman, A.,... Allanore, Y. (2017). Mapping and predicting mortality from systemic sclerosis. Annals of the Rheumatic Diseases. https://dx.doi.org/10.1136/annrheumdis-2017-211448
Hsu, V.M., Denton, C.P., Domsic, R.T., Furst, D.E., Rischmueller, M., Stanislav, M.,... Hough, D.R. (2017). Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study. Journal of Rheumatology. https://dx.doi.org/10.3899/jrheum.161040

Zuletzt aktualisiert 2017-04-11 um 15:34